Covid-19 booster jab programme gets under way The NHS will contact people when it is their turn to book their vaccine. The Independent UK · Sep 5, 2022
Omicron boosters: Do I need one, and if so, when? Updated COVID boosters are now available for anyone age 12 or older. The CDC is urging anyone who is eligible to sign up but some vaccine experts say some people might want to wait. WEKU · Sep 5, 2022
Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it Fainting and fatigue may signal onset of variant, experts say The Independent UK · Sep 5, 2022
Millions to be offered Covid booster jabs from today amid autumn campaign The NHS will be calling on care home residents to book their Covid vaccine for the autumn Manchester Evening News · Sep 5, 2022
Young SA children to get COVID-19 vaccine South Australia will start vaccinating children under five who have pre-existing health conditions against COVID-19. AAP · Sep 5, 2022
Better COVID vaccines are on the way. What do they do? And what technology might we see in future? Regulators in Australia and the United States last week approved Omicron-specific boosters, following approval in the United Kingdom in mid-August. The Conversation · Sep 4, 2022
Can my pet get monkeypox? Here's what veterinarians say Experts reveal what we know so far about monkeypox and pets, including how to protect your pet from it. Inverse · Sep 4, 2022
India develops indigenous cervical cancer vaccine to save millions of lives India's homegrown cervical cancer shot, announced on Thursday, will be made available first to the country's poorest before being exported to other countries in need. Radio France Internationale · Sep 4, 2022
CanSino's inhaled Covid-19 vaccine gets emergency use approval in China HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed Covid-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. Bangkok Post · Sep 4, 2022
CanSino's inhaled COVID-19 vaccine gets emergency use approval in China China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. Reuters · Sep 4, 2022
Medical board set up to treat 12-year-old rabies patient The girl, a native of Ranni, was bitten by a stray dog two weeks ago The Hindu · Sep 3, 2022
Second Covid booster jab approved in UK ahead of winter vaccine programme It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK Evening Standard · Sep 3, 2022
New 'second generation' Pfizer Covid vaccine approved ahead of booster programme The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month Daily Mirror · Sep 3, 2022
A new vaccine which protects against two strains of covid has been approved for the NHS to use this autumn It targets both the original strain of coronavirus and the Omicron variant Manchester Evening News · Sep 3, 2022
The Independent UK · Sep 3, 2022 Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it Fainting and fatigue may signal onset of variant, experts say
The Independent UK · Sep 3, 2022 Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator The vaccine targets both the original strain of coronavirus and the Omicron variant.
The Guardian - UK · Sep 3, 2022 Millions in England to be invited for Covid booster from Monday NHS launches autumn drive with jabs offered first to care home staff and residents, and housebound people
Glasgow Live · Sep 3, 2022 Glasgow parents urged to ensure children are vaccinated against flu as winter approaches NHSGGC has confirmed that letters have been sent out to children aged two to five who are not yet in school, giving them their appointment time for the winter flu vaccine.
Dynamite News · Sep 3, 2022 Bombay HC issues notice to Central govt, Bill Gates, Serum Institute over plea on alleged Covid vaccine death Dilip Lunawat in his petition, "blamed the Government and others for misrepresenting the facts about the COVID-19 vaccine by making false claims about its safety and 'forcing' medical practitioners to take the vaccine. Read more on Dynamite News:
Dynamite News · Sep 3, 2022 Health: Immense efforts are on for next-generation COVID vaccines According to Dr NK Arora Chairperson of COVID-19 working group NTAGI, "This whole concept of next-generation vaccine is that we don't have to give repeated doses. Read more on Dynamite News:
Wales Online · Sep 3, 2022 1.6m care home residents, staff and housebound first in line for Covid booster in England Health teams will visit care homes and private homes to vaccinate around 1.6 million residents, staff and housebound people in the latest phase of the vaccine rollout
Daily Mirror · Sep 2, 2022 4 million Brits invited to get variant-busting Covid jabs next week - see who Around four million others, including the over 75s and those with weakened immune systems, will also be eligible to book a vaccine through the National Booking Service from Monday
Los Angeles Times · Sep 2, 2022 Los Angeles clinic diluted more than 2,000 doses of COVID-19 vaccine LOS ANGELES — A Los Angeles clinic diluted more than 2,000 doses of the COVID-19 vaccine, and did not inform some patients until months later, according to a report.
StockNews.com · Sep 2, 2022 3 Stocks to Buy That Won’t Give You Any Headaches The stock market has witnessed significant volatility amid the record high inflation and the Fed’s hawkish stance on it. Investors have been banking on healthcare stocks as they tend to hold up relatively well in such turbulent times. We think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer…
Al Jazeera · Sep 2, 2022 ‘Completely new’ COVID strains possible in winter: EU drug agency Existing vaccines and adaptive ones should protect people from serious illness and death, the EU agency says.